Ensysce Biosciences (ENSC) Earnings Date & Reports

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ENSC is expected to report earnings to fall 120.00% to 3 cents per share on November 16

Ensysce Biosciences ENSC Stock Earnings Reports

Q3'26

Est.

$0.04

Q2'26

Beat

by $0.51

Q1'26

Beat

by $0.30

Q4'25

Beat

by $0.33

Q3'25

Missed

by $0.22

The last earnings report on August 24 showed earnings per share of -20 cents, beating the estimate of -70 cents. With 477.23K shares outstanding, the current market capitalization sits at 7.26M.

View a ticker or compare two or three

ENSC

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days